EAM
Erste Asset Management Portfolio holdings
AUM
$11.9B
This Quarter Return
+17.19%
1 Year Return
+22.95%
3 Year Return
+112.82%
5 Year Return
+205.55%
10 Year Return
–
AUM
$2.26B
AUM Growth
+$2.26B
(+20%)
Cap. Flow
+$129M
Cap. Flow
% of AUM
5.69%
Top 10 Holdings %
Top 10 Hldgs %
22.4%
Holding
1,083
New
33
Increased
159
Reduced
65
Closed
38
Top Buys
| 1 |
Biogen
BIIB
|
$42.6M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
$15.3M |
| 3 |
Agios Pharmaceuticals
AGIO
|
$12.9M |
| 4 |
Westlake Corp
WLK
|
$8.83M |
| 5 |
Booking.com
BKNG
|
$7.2M |
Top Sells
| 1 |
Vertex Pharmaceuticals
VRTX
|
$28.7M |
| 2 |
CELG
Celgene Corp
CELG
|
$20.8M |
| 3 |
TIF
Tiffany & Co.
TIF
|
$9.53M |
| 4 |
iShares Semiconductor ETF
SOXX
|
$7.76M |
| 5 |
Roper Technologies
ROP
|
$5.92M |
Sector Composition
| 1 | Healthcare | 30.5% |
| 2 | Technology | 20.83% |
| 3 | Consumer Discretionary | 13.27% |
| 4 | Financials | 9.34% |
| 5 | Communication Services | 6.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
FirstService
FSV
$9.17B
| $5.6M | 0.25% | 60,000 +8,000 | +15% | +$747K |
|
102
Openlane
KAR
$3.07B
| $5.53M | 0.24% | 255,000 +11,000 | +5% | +$238K |
|
|
JNCE
103
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $5.47M | 0.24% | 672,687 +40,000 | +6% | +$325K |
|
104
Xencor
XNCR
$580M
| $5.3M | 0.23% | 154,200 | – | – |
|
105
PNC Financial Services
PNC
$81.7B
| $5.24M | 0.23% | 32,665 -5,662 | -15% | -$908K |
|
|
TPIC
106
DELISTED
TPI Composites
TPIC
| $5.15M | 0.23% | 278,484 +8,884 | +3% | +$164K |
|
107
Salesforce
CRM
$245B
| $5.13M | 0.23% | 31,090 +300 | +1% | +$49.5K |
|
|
GBT
108
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.05M | 0.22% | 63,800 | – | – |
|
109
Guardant Health
GH
$8.41B
| $5M | 0.22% | +63,500 | New | +$5M |
|
|
NOVA
110
DELISTED
Sunnova Energy
NOVA
| $5M | 0.22% | 430,000 +320,000 | +291% | +$3.72M |
|
111
Comcast
CMCSA
$125B
| $4.98M | 0.22% | 110,401 +10,990 | +11% | +$495K |
|
|
ZGNX
112
DELISTED
Zogenix, Inc.
ZGNX
| $4.91M | 0.22% | 94,900 | – | – |
|
|
TERP
113
DELISTED
TerraForm Power, Inc
TERP
| $4.82M | 0.21% | 317,490 -20,000 | -6% | -$304K |
|
|
RETA
114
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $4.78M | 0.21% | 22,600 | – | – |
|
115
Intercontinental Exchange
ICE
$101B
| $4.74M | 0.21% | 51,103 +4,832 | +10% | +$448K |
|
116
Manulife Financial
MFC
$52.2B
| $4.69M | 0.21% | 232,500 +10,100 | +5% | +$204K |
|
117
Pfizer
PFE
$141B
| $4.63M | 0.2% | 117,720 +8,500 | +8% | +$334K |
|
|
ONC
118
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $4.61M | 0.2% | 27,600 | – | – |
|
119
FibroGen
FGEN
$47.8M
| $4.43M | 0.2% | 98,600 +24,900 | +34% | +$1.12M |
|
120
Gildan
GIL
$8.14B
| $4.39M | 0.19% | 148,600 -25,500 | -15% | -$754K |
|
121
Advanced Micro Devices
AMD
$264B
| $4.39M | 0.19% | 95,000 +15,000 | +19% | +$693K |
|
122
Voyager Therapeutics
VYGR
$186M
| $4.33M | 0.19% | 320,900 +15,000 | +5% | +$203K |
|
123
Toronto Dominion Bank
TD
$128B
| $4.31M | 0.19% | 76,660 -1,750 | -2% | -$98.4K |
|
124
Eli Lilly
LLY
$657B
| $4.29M | 0.19% | 32,600 +2,100 | +7% | +$276K |
|
125
Brookfield Renewable
BEP
$7.2B
| $4.16M | 0.18% | 88,800 -8,000 | -8% | -$375K |
|